Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Avi Kapoor

KalVista Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Two,Diverse,Crypto,Traders,Brokers,Stock,Exchange,Market,Investors,Discussing

KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) will release earnings results for the first quarter before the opening bell on Thursday, Sept. 11.

Analysts expect the Cambridge, Massachusetts-based company to report a quarterly loss at 96 cents per share, versus a year-ago loss of 87 cents per share. KalVista Pharmaceuticals projects to report quarterly revenue of $2.09 million, according to data from Benzinga Pro.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.